In this study, we have identified high frequencies of cancer specific abnormal hypermethylation of the parts of promoter regions of integrin ITGA1, ITGA4, ITGA9, and nidogen NID1, NID2 genes in breast cancer. This evidence concerns the gene NID2 and breast carcinoma.